Compare IGC & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IGC | RMTI |
|---|---|---|
| Founded | 2005 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 34.0M |
| IPO Year | N/A | 1998 |
| Metric | IGC | RMTI |
|---|---|---|
| Price | $0.29 | $1.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $4.13 | $2.50 |
| AVG Volume (30 Days) | 634.9K | ★ 1.4M |
| Earning Date | 02-17-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,106,000.00 | ★ $75,577,000.00 |
| Revenue This Year | $3.54 | N/A |
| Revenue Next Year | $15.12 | $8.12 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.25 | $0.78 |
| 52 Week High | $0.50 | $2.27 |
| Indicator | IGC | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 69.29 |
| Support Level | $0.29 | $0.92 |
| Resistance Level | $0.30 | $0.99 |
| Average True Range (ATR) | 0.01 | 0.07 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 20.75 | 84.69 |
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.